IN2013MU02442A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MU02442A IN2013MU02442A IN2442MU2013A IN2013MU02442A IN 2013MU02442 A IN2013MU02442 A IN 2013MU02442A IN 2442MU2013 A IN2442MU2013 A IN 2442MU2013A IN 2013MU02442 A IN2013MU02442 A IN 2013MU02442A
- Authority
- IN
- India
- Prior art keywords
- formula
- compounds
- present
- pharmaceutically acceptable
- pharmaceutical composition
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
ABSTRACT Formulation comprising a hypolipidemic agent The present invention provides a stable pharmaceutical composition of a suitable hypolipidemic agent. Preferably, the present invention discloses novel formulations of the compound of formula (I), or pharmaceutically acceptable salts of compounds of formula (I). More particularly the present invention relates to stable pharmaceutical composition of compounds of formula (I) comprising compounds of formula (I) or its pharmaceutically acceptable salts. formula (I)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2442MU2013 IN2013MU02442A (en) | 2013-07-22 | 2013-07-22 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2442MU2013 IN2013MU02442A (en) | 2013-07-22 | 2013-07-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2013MU02442A true IN2013MU02442A (en) | 2015-06-19 |
Family
ID=54396653
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2442MU2013 IN2013MU02442A (en) | 2013-07-22 | 2013-07-22 |
Country Status (1)
Country | Link |
---|---|
IN (1) | IN2013MU02442A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020165782A1 (en) * | 2019-02-13 | 2020-08-20 | Cadila Healthcare Limited | Treatment for polycystic ovarian syndrome (pcos) |
-
2013
- 2013-07-22 IN IN2442MU2013 patent/IN2013MU02442A/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020165782A1 (en) * | 2019-02-13 | 2020-08-20 | Cadila Healthcare Limited | Treatment for polycystic ovarian syndrome (pcos) |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018502747A1 (en) | Boronic acid derivatives and therapeutic uses thereof | |
PH12015502802A1 (en) | Formulation comprising a hypolipidemic agent | |
NZ716840A (en) | Combination formulation of two antiviral compounds | |
MX2015008628A (en) | Boronic acid derivatives and therapeutic uses thereof. | |
PH12016500467A1 (en) | Aminoheteroarlyl benzamides as kinase inhibitors | |
PH12015501996A1 (en) | Heterocyclic compounds and uses thereof | |
MX2015008627A (en) | Boronic acid derivatives and therapeutic uses thereof. | |
MX2016016666A (en) | Boronic acid derivatives and therapeutic uses thereof. | |
MX2016015093A (en) | Boronic acid derivatives and therapeutic uses thereof. | |
MX2011010311A (en) | Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same. | |
MX2011010415A (en) | Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof. | |
MY187718A (en) | Pharmaceutical formulations | |
MX364400B (en) | Tetracycline compounds. | |
MX2016001422A (en) | Pharmaceutical compositions of fingolimod. | |
PH12016500461A1 (en) | Polyethylene glycol-containing composition | |
PH12016500577B1 (en) | Piperazine derivatives and the use thereof as medicament | |
WO2015002755A3 (en) | Compounds for the treatment of malaria | |
WO2014166836A8 (en) | Growth hormone compound formulation | |
MY181682A (en) | Stabilised amorphous form of agomelatine, a process for its preparation and pharmaceutical compositions containing it | |
IN2013MU02442A (en) | ||
PH12015502703A1 (en) | Pharmaceutical compositions | |
MX2015004315A (en) | Flavor and fragrance formulation (vi). | |
SA112330437B1 (en) | Pharmaceutical compositions containing hypnotic or anesthetic agent and method for their preparation |